Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Hematologic Neoplasms 2COVID-19 2Skin Neoplasms 1Respiratory Sounds 1Respiratory Distress Syndrome 1Pneumonia, Viral 1Pharmacokinetics 1Neoplasms 1Lymphoma, Follicular 1Cytokine Release Syndrome 1Crohn Disease 1Bronchiolitis Obliterans Syndrome 1Asthma 1Adenomatous Polyposis Coli 1

Interventions

Azithromycin 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pharmacokinetics × Azithromycin × Clear all
NCT00644176 2011-06-08

A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery

Pfizer

Phase 2 Completed
66 enrolled

Pharmacokinetics

Data powered by HemOnc (CC BY 4.0) Colophon âš¡